The diagnosis of polycystic ovary syndrome: The criteria are insufficiently robust for clinical research

Clinical Endocrinology

Volumn 67, Issue 6, 2007, Pages 811-815

  Barth, Julian H ^a   Yasmin, Ephia ^a   Balen, Adam H ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANOVULATION; DIAGNOSTIC ERROR; ECHOGRAPHY; HUMAN; HYPERANDROGENISM; INSULIN SENSITIVITY; LABORATORY TEST; MEDICAL RESEARCH; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

ANOVULATION; FEMALE; HUMANS; HYPERANDROGENISM; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 36248944988     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02932.x     Document Type: Review

References (51)

1. Cussons, A.J., Stuckey, B.G.A., Walsh, J.P., Burke, V. Norman, R.J. (2005) Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clinical Endocrinology, 62, 289 295.
2. Stein, I.F. Leventhal, M.L. (1935) Amenorrhoea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology, 29, 181 191.
3. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group revised 2003) Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41 47.
4. Azziz, R. (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. Journal of Clinical Endocrinology and Metabolism, 91, 781 785.
5. Franks, S. (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Journal of Clinical Endocrinology and Metabolism, 91, 786 789.
6. Belosi, C., Selvaggi, L., Apa, R., Guido, M., Romualdi, D., Fulghesu, A.M. Lanzone, A. (2006) Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma. Human Reproduction, 21, 3108 3115.
7. Balen, A.H. Michelmore, K. (2002) What is polycystic ovary syndrome? Are national views important? Human Reproduction, 17, 2219 2227.
8. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., Janssen, O.E., Legro, R.S., Norman, R.J., Taylor, A.E. Witchel, S.F. (2006) Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of Clinical Endocrinology and Metabolism, 91, 4237 4245.
9. Goulden, V., Stables, G.I. Cunliffe, W.J. (1999) Prevalence of facial acne in adults. Journal of the American Academy of Dermatology, 41, 577 580.
10. Rushton, H., Lyons, G.M., Firth, P.S., Abrahams, R. James, K.C. (1986) Scalp hair, facial skin and pregnancy. Journal of Obstetrics and Gynaecology, 7, 51 52.
11. Welt, C.K., Gudmundsson, J.A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G. Ingadottir, Crowley, W.F. (2006) Characterising discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism, 91, 4842 4848.
12. Ferriman, D. Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology, 21, 1440 1447.
13. DeUgarte, C.M., Woods, K.S., Bartolucci, A.A. Azziz, R. (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a population definition of hirsutism. Journal of Clinical Endocrinology and Metabolism, 91, 1345 1350.
14. British Institute Association of Electrolysis. http://www.electrolysis. co.uk/index.html (accessed 26 February 2007).
15. Barth, J.H. (1997) How hairy are hirsute women? Clinical Endocrinology, 47, 255 260.
16. Lunde, O. Grottum, P. (1984) Body hair growth in women: normal or hirsute. American Journal of Physical Anthropology, 64, 307 313.
17. Barth, J.H., Catalan, J., Cherry, C.A. Day, A.E. (1993) Psychological morbidity in women referred for treatment of hirsutism. Journal of Psychosomatic Research, 37, 615 619.
18. Shah, P.N. (1957) Human body hair - a quantitative study. American Journal of Obstetrics and Gynecology, 73, 1255 1265.
19. Barth, J.H., Cherry, C.A., Wojnarowska, F. Dawber, R.P.R. (1991) Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study. Clinical Endocrinology, 35, 5 10.
20. Barth, J.H. (1996) How robust is the methodology for trials of therapy in hirsute women? Clinical Endocrinology, 45, 379 380.
21. Wild, R.A., Vesely, S., Beebe, L., Whitsett, T. Owen, W. (2005) Ferriman Gallwey self-scoring 1: performance assessment in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 90, 4112 4114.
22. Gibson, J.R., Harvey, S.G., Barth, J.H., Darley, C.R., Reshad, H.R. Burke, C.A. (1984) Assessing inflammatory acne vulgaris: correlation between clinical and photographic methods. British Journal of Dermatology, 111 (Suppl. 27 168 170.
23. De Villez, R.L. Dunn, J. (1986) Female androgenic alopecia: the 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness. Archives of Dermatology, 122, 1011 1015.
24. Rushton, D.H., Ramsay, I.D., James, K.C., Norris, M.J. Gilkes, J.J. (1990) Biochemical and trichological characterization of diffuse alopecia in women. British Journal of Dermatology, 123, 187 197.
25. Cela, E., Robertson, C., Rush, K., Kousta, E., White, D.M., Wilson, H., Lyons, G., Kingsley, P., McCarthy, M.I. Franks, S. (2003) Prevalence of polycystic ovaries in women with androgenic alopecia. European Journal of Endocrinology, 149, 439 442.
26. Ludwig, E. (1977) Classification of the types of androgenic alopecia (common baldness) arising in the female sex. British Journal of Dermatology, 97, 247 254.
27. Norwood, O.T.T. (1975) Male pattern baldness: classification and incidence. Southern Medical Journal, 68, 1359 1365.
28. Venning, V.A. Dawber, R.P.R. (1988) Patterned androgenic alopecia. Journal of the American Academy of Dermatology, 18, 1073 1078.
29. Rosner, W., Auchus, R.J., Azziz, R., Sluss, P.M. Raff, H. (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405 413.
30. Warner, M.H., Kane, J.W., Atkin, S.L. Kilpatrick, E.S. (2006) Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. Annals of Clinical Biochemistry, 43, 196 199.
31. Jayagopal, V., Kilpatrick, E.S., Jennings, P.E., Hepburn, D.A. Atkin, S.L. (2003) The biological variation of testosterone and sex hormone binding globulin (SHBG) in polycystic vary syndrome: implications for SHBG as a surrogate marker of insulin resistance. Journal of Clinical Endocrinology and Metabolism, 88, 1528 1533.
32. Cawood, M.L., Field, H.P., Ford, C.G., Gillingwater, S., Kicman, A., Cowan, D. Barth, J.H. (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practise. Clinical Chemistry, 51, 1472 1479.
33. Gilling-Smith, C., Story, H., Rogers, V. Franks, S. (1997) Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clinical Endocrinology, 47, 93 99.
34. Fauser, B.C.J.M., Pache, T.D., Hop, W.C.J., de Jong, F.H. Dahl, K.D. (1992) The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates. Clinical Endocrinology, 37, 445 452.
35. Escobar-Morreale, H.F., Asuncion, M., Calvo, R.M., Sancho, J. San Millan, J.L. (2001) Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. European Journal of Endocrinology, 145, 619 624.
36. Knochenhauer, E.S., Key, T.J., Kahsar-Miller, M., Waggoner, W., Boots, L.R. Azziz, R. (1988) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism, 83, 3078 3082.
37. Middle, J.G. UK NEQAS 2006) Steroid Hormones Annual Review for Progesterone. (Available from the author at UK NEQAS, PO Box 3909, Birmingham B15 2UE, UK).
38. Balen, A.H., Laven, J.S.E., Tan, S.L. Dewailly, D. (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update, 9, 505 514.
39. Jonard, S., Robert, Y. Dewailly, D. (2005) Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries? Human Reproduction, 20, 2893 2898.
40. Allemand, M., Tummon, I.S., Phy, J.L., Foong, S.C., Dumesic, D.A. Session, D.R. (2006) Diagnosis of polycystic ovaries by three dimensional transvaginal ultrasound. Fertility and Sterility, 85, 214 219.
41. Amer, S.A.K.S., Li, T.C., Bygrave, C., Sprigg, A., Sravelos, H. Cooke, I.D. (2002) An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Human Reproduction, 17, 1616 1622.
42. Jayagopal, V., Kilpatrick, E.S., Holding, S., Jennings, P.E. Atkin, S.L. (2002) The biological variation of insulin resistance in polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 1560 1562.
43. Marcovina, S., Bowsher, R.R., Miller, W.G., Staten, M., Myers, G., Caudill, S.P., Campbell, S.E. Steffes, M.W. for the Insulin Standardization Workgroup (2007) Standardization of insulin immunoassays: report of the American Diabetes Association workgroup. Clinical Chemistry, 53, 711 716.
44. Rickenlund, A., Thoren, M., Carlstrom, K., von Schoultz, B. Hirschberg, A.L. (2004) Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. Journal of Clinical Endocrinology and Metabolism, 89, 702 707.
45. Garde, A.H., Hansen, A.M., Skovgaard, L.T. Christensen, J.M. (2000) Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A (1c), IgA, prolactin, and free testosterone in healthy women. Clinical Chemistry, 46, 551 559.
46. Azziz, R., Bradley, E. Jr., Huth, J., Boots, L.R., Parker, C.R. Jr. Zacur, H.A. (1990) Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time. Journal of Clinical Endocrinology and Metabolism, 70, 1273 1279.
47. Massafra, C., De Felice, C., Agnusdei, D.P., Gioia, D. Bagnoli, F. (1999) Androgens and osteocalcin during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 84, 971 974.
48. Maes, M., Mommen, K., Hendrickx, D., Peeters, D., D'Hondt, P., Ranjan, R., De Meyer, F. Scharpe, S. (1997) Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clinical Endocrinology, 46, 587 598.
49. Winters, S.J., Talbott, E., Guzick, D.S., Zborowski, J. McHugh, K.P. (2000) Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertility and Sterility, 73, 724 729.
50. Zumoff, B., Strain, G.W., Miller, L.K. Rosner, W. (1995) Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. Journal of Clinical Endocrinology and Metabolism, 80, 1429 1430.
51. Torjesen, P.A. Bjoro, T. (1996) Antibodies against [125I] testosterone in patient's serum: a problem for the laboratory and the patient. Clinical Chemistry, 42, 2047 2048.